By Adam Rhodes ( July 17, 2019, 6:05 PM EDT) -- Pharmaceutical giant Takeda hit up would-be buyers about a portfolio of Western European drugs, Reuters reported on Wednesday. Citing anonymous sources, Reuters reported that the Japanese drugmaker wants roughly €1.5 billion ($1.68 billion) for the drugs, which include prescription and over-the-counter products. According to the report, JPMorgan is helping to find a buyer for the drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.